The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Effects of Trientine, a Metal Chelator, on Defective Endothelium-dependent Relaxation in the Mesenteric Vasculature of Diabetic Rats
Abstract
Diabetes mellitus compromises endothelium-dependent relaxation of blood vessels. This has been linked to the generation of reactive oxygen species (ROS), which neutralise nitric oxide (NO) and interfere with vasodilator function. Experiments using chelators have emphasised the importance of ROS produced by transition metal catalysed reactions. However, particularly for the small arteries and arterioles that control microcirculatory blood flow, NO is not the only endothelium-derived mediator; endothelium-derived hyperpolarizing factor (EDHF) has a major role. EDHF-mediated vasodilation is severely curtailed by diabetes; however, little information exists on the underlying pathophysiology. Deficits in the EDHF system, alone or in combination with the NO system, are crucial for the development of diabetic microvascular complications. To further elucidate the mechanisms involved, the aim was to examine the effects of diabetes and preventive and intervention chelator therapy with trientine on a preparation that has well-defined NO and EDHF-mediated responses, the rat mesenteric vascular bed. In phenylephrine-preconstricted preparations, maximum vasodilation to acetylcholine was reduced by 35 and 44% after 4 and 8 weeks of streptozotocin-induced diabetes, respectively. Trientine treatment over the first 4 weeks gave 72% protection; intervention therapy over the final 4 weeks prevented deterioration and corrected the initial deficit by 68%. These responses depend on both NO and EDHF. When the latter mechanism was isolated by NO synthase inhibition, diabetic deficits of 53.4 (4 weeks) and 65.4% (8 weeks) were revealed, that were 65% prevented and 50% corrected by trientine treatment. Neither diabetes nor trientine altered vascular smooth muscle responses to the NO donor, sodium nitroprusside (SNP). Thus, the data suggest that metal catalysed ROS production makes a substantial contribution to defects in both the EDHF and NO endothelial mechanisms in diabetes, which has therapeutic implications for microvascular complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because metal chelators and hydroxyl radical scavengers have also been demonstrated to be effective in preventing diabetes-induced vascular and neural dysfunction, it is likely that the formation of hydroxyl radicals also contributes to impairment of vascular reactivity and nerve function in diabetes (46–51, 145).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [145]
In the citing paper
“Cameron and colleagues (46, 48–50, 145) demonstrated that treating diabetic rats with α-lipoic acid or the metal chelators, hydroxyethyl starch deferoxamine or trientine, prevented the diabetes-induced impairment in vascular relaxation associated with hyperalgesia and neurovascular deficits.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [145]
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,117
K+ is an endothelium-derived hyperpolarizing factor in rat arteries
Edwards, G., Dora, K. A., Gardener, M. J., Garland, C. J., & Weston, A. H. (1998) · Nature · doi:10.1038/24388 · Cited by 1,057
de Tejada, I. S., Goldstein, I., Azadzoi, K. M., Krane, R. J., & Cohen, R. A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904203201601 · Cited by 944
McVeigh, G. E., Brennan, G. M., Johnston, G. D., McDermott, B. J., McGrath, L. T., Henry, W. R., Andrews, J. W., & Hayes, J. R. (1992) · Diabetologia · doi:10.1007/bf00429099 · Cited by 916
Diabetes mellitus and free radicals
Wolff, S. P. (1993) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072637 · Cited by 660
Moncada, S., Rees, D. D., Schulz, R., & Palmer, R. M. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2166 · Cited by 489
Hecker, M., Bara, A. T., Bauersachs, J. K., & Busse, R. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020449 · Cited by 418
Impairment of endothelium‐dependent relaxation in aortae from spontaneously diabetic rats
Durante, W., Sen, A. K., & Sunahara, F. A. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11548.x · Cited by 250
Cameron, N. E., Cotter, M. A., Archibald, V., Dines, K. C., & Maxfield, E. K. (1994) · Diabetologia · doi:10.1007/s001250050131 · Cited by 240
Self-citationCameron, N. E., & Cotter, M. A. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100302 · Cited by 224
Self-citationCameron, N. E., & Cotter, M. A. (1992) · Diabetologia · doi:10.1007/bf02221675 · Cited by 213
Self-citationVascular factors in diabetic neuropathy
Tesfaye, S. H., Malik, R. A., & Ward, J. D. (1994) · Diabetologia · doi:10.1007/bf00400938 · Cited by 211
Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta
Pieper, G. M., & Gross, G. J. (1988) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1988.255.4.h825 · Cited by 192
Obrosova, I. G., Minchenko, О. H., Marinescu, V., Fathallah, L., Kennedy, A., Stockert, C. M., Frank, R. N., & Stevens, M. (2001) · Diabetologia · doi:10.1007/s001250100631 · Cited by 179
Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus
Mayhan, W. G. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.256.3.h621 · Cited by 170
Amelioration by L-Arginine of a Dysfunctional Arginine/Nitric Oxide Pathway in Diabetic Endothelium
Pieper, G. M., & Peltier, B. A. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199503000-00008 · Cited by 162
R�sen, P., Ballhausen, T., Bloch, W., & Addicks, K. (1995) · Diabetologia · doi:10.1007/bf00422364 · Cited by 160
Fukao, M., Hattori, Y., Kanno, M., Sakuma, I., & Kitabatake, A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701258 · Cited by 155
VEGF transiently disrupts gap junctional communication in endothelial cells
Suarez, S., & Ballmer‐Hofer, K. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.6.1229 · Cited by 147
Cameron, N. E., & Cotter, M. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118104 · Cited by 147
Self-citationRole of gap junctions in the responses to EDHF in rat and guinea‐pig small arteries
Edwards, G., Félétou, M., Gardener, M. J., Thollon, C., Vanhoutte, P. M., & Weston, A. H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703009 · Cited by 144
McNally, P. G., Watt, P. A. C., Rimmer, T., Burden, A. C., Hearnshaw, J. R., & Thurston, H. (1994) · Clinical Science · doi:10.1042/cs0870031 · Cited by 139
Keegan, A., Walbank, H., Cotter, M. A., & Cameron, N. E. (1995) · Diabetologia · doi:10.1007/bf00400609 · Cited by 136
Self-citationFélétou, M., & Vanhoutte, P. M. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0840 · Cited by 125
Brogden, R. N., Heel, R. C., Speight, T. M., & Avery, G. S. (1979) · Drugs · doi:10.2165/00003495-197918060-00001 · Cited by 124
Endocannabinoids: a new class of vasoactive substances
Randall, M. D., & Kendall, D. A. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01161-9 · Cited by 123
Cotter, M. A., Love, A., Watt, M. J., Cameron, N. E., & Dines, K. C. (1995) · Diabetologia · doi:10.1007/bf00401760 · Cited by 118
Self-citationKeegan, A., Cotter, M. A., & Cameron, N. E. (1999) · Diabetologia · doi:10.1007/s001250051161 · Cited by 114
Self-citationAltered Tissue Content and Cytosol Distribution of Trace Metals in Experimental Diabetes
Failla, M. L., & Kiser, R. A. (1981) · Journal of Nutrition · doi:10.1093/jn/111.11.1900 · Cited by 111
Makino, A., Ohuchi, K., & Kamata, K. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703354 · Cited by 107
Increased Nitrotyrosine in the Diabetic Placenta: Evidence for oxidative stress
Lyall, F., Gibson, J. L., Greer, I. A., Brockman, D. E., Eis, A., & Myatt, L. (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1753 · Cited by 101
Induction of Nitric Oxide Synthase Inhibits Gap Junction Permeability in Cultured Rat Astrocytes
Bolaños, J. P., & Medina, J. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66052091.x · Cited by 97
Heygate, K. M., Lawrence, I. G., Bennett, M., & Thurston, H. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15132.x · Cited by 92
Sunano, S., Watanabe, H., Tanaka, S., Sekiguchi, F., & Shimamura, K. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702355 · Cited by 92
Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes
Tooke, J. E. (2000) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00083-0 · Cited by 88
Vargas, H. M., Cuevas, J., Ignarro, L. J., & Chaudhuri, G. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24690-0 · Cited by 84
Whiteman, M., & Halliwell, B. B. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00545-x · Cited by 83
Effect of α-lipoic acid on vascular responses and nociception in diabetic rats
Cameron, N. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00564-0 · Cited by 83
Self-citationFujii, K., Heistad, D. D., & Faraci, F. M. (1992) · Stroke · doi:10.1161/01.str.23.10.1494 · Cited by 82
Pieper, G. M., & Siebeneich, W. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199712000-00006 · Cited by 81
Zygmunt, P. M., Ryman, T., & Högestätt, E. D. (1995) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1995.tb09972.x · Cited by 72
Archibald, V., Cotter, M. A., Keegan, A., & Cameron, N. E. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169180 · Cited by 57
Self-citationEffects of an extracellular metal chelator on neurovascular function in diabetic rats
Cameron, N. E., & Cotter, M. A. (2001) · Diabetologia · doi:10.1007/s001250051669 · Cited by 54
Self-citationPieper, G. M., Siebeneich, W., Roza, A. M., Jordan, M., & Adams, M. B. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199612000-00002 · Cited by 50
Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease
Siegemund, T., Lössner, J., Günther, K., Kühn, H.-J., & Bachmann, H. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb03964.x · Cited by 48
Glycochelates and the etiology of diabetic peripheral neuropathy
Qian, M., & Eaton, J. W. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00262-2 · Cited by 42
Keegan, A., Jack, A. M., Cotter, M. A., & Cameron, N. E. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200004000-00014 · Cited by 40
Self-citationEffects of chelator treatment on aorta and corpus cavernosum from diabetic rats
Keegan, A., Cotter, M. A., & Cameron, N. E. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00125-2 · Cited by 37
Self-citationTribe, R. M., Thomas, C. R., & Poston, L. (1998) · Diabetologia · doi:10.1007/s001250050863 · Cited by 36
L-Arginine Does Not Restore Dilatation of the Basilar Artery during Diabetes Mellitus
Mayhan, W. G., Didion, S. P., & Patel, K. P. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199605000-00017 · Cited by 27
Endothelial dysfunction in the perfused kidney from the streptozotocin-induced diabetic rat.
Kamata, K., & Hosokawa, M. (1997) · PubMed · Cited by 27
Histamine relaxation of aortic rings from diabetic rats
Tanz, R. D., Chang, K. S. K., & Weller, T.-S. (1989) · Inflammation Research · doi:10.1007/bf02022973 · Cited by 21
Iseki, K., Kobayashi, M., Ohba, A., Miyazaki, K., Li, Y., Togashi, Y., & Takeichi, N. (1992) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510130406 · Cited by 16
Cited by
Sorted by citations
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
“…thus scavenging of NO and increased presence of peroxynitrite (Cosentino et al. 1997, Mayhan & Patel 1998, Graier et al. 1999, Maejima et al. 2001, Inkster et al. 2002, Pannirselvam et al. 2002, Pacher & Szabo 2006, Duncan et al. 2007, Quijano et al. 2007, Gao et al. 2008, L€uscher & Steffel…”
BackgroundEndothelial dysfunction and vascular disease
Vanhoutte, P. M., Shimokawa, H., Tang, E. H. C., & Félétou, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01964.x · Cited by 824
Sivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
Reactive oxygen species and endothelial function in diabetes
Fatehi‐Hassanabad, Z., Chan, C. B., & Furman, B. L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.048 · Cited by 165
“ed by both nitric oxide and EDHF in the rat mesenteric vascular bed (Inkster et al., 2002).”
BackgroundEDHF: new therapeutic targets?
Félétou, M. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.10.017 · Cited by 136
Metadata
- Authors
- Inkster, M. E., Cotter, M. A., & Cameron, N. E.
- Affiliations
- University of Aberdeen (GB)
- Venue
- Free Radical Research
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 36
- Issue
- 10
- Pages
- 1091-1099
- ISSN
- 1029-2470 (ISSN-L)
- 1071-5762
- OpenAlex
- W1987191170
- Cited by
- 26
- References
- 54
- Citations by year
- 2025: 1 · 2023: 1 · 2021: 1 · 2015: 3 · 2014: 1 · 2013: 1
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Free Radical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- triethylenetetramine, metal chelators, endothelium-dependent relaxation, diabetes mellitus, endothelium-derived hyperpolarizing factor, nitric oxide, reactive oxygen species, transition metal catalysis, mesenteric vasculature, streptozotocin-induced diabetes, acetylcholine, sodium nitroprusside, nitric oxide synthase, diabetic microvascular complications, vascular smooth muscle
- MeSH terms
- Acetylcholine, Animals, Biological Factors, Chelating Agents, Diabetes Mellitus, Experimental, Endothelium, Vascular, Enzyme Inhibitors, Male, Nitric Oxide, Nitroprusside, Phenylephrine, Splanchnic Circulation, Trientine, Vasoconstrictor Agents, Vasodilation, Rats, Sprague-Dawley, Nitric Oxide Synthase, Nitroarginine, Nitric Oxide Donors, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review